Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways

Ligang Zhou, Gregory M. Sutton, Justin J. Rochford, Robert K. Semple, Daniel D. Lam, Laura J. Oksanen, Zoe D. Thornton-Jones, Peter G. Clifton, Chen-Yu Yueh, Mark L. Evans, Rory J. McCrimmon, Joel K. Elmquist, Andrew A. Butler, Lora K. Heisler*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

198 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways'. Together they form a unique fingerprint.

Medicine & Life Sciences